
Good morning. Fortune senior writer Maria Aspan here.
“We will do anything to survive outside of bankruptcy.” CEO Saundra Pelletier has spent the past year watching her pharma company, Evofem Biosciences, slowly slip to the brink of failure. She also spent the past two months talking to me about her company’s struggles, offering Fortune’s readers a rare window into how top executives manage through—and try to avert—the ultimate business disaster.